Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab (2018)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacl.2018.03.088
- Subjects: DOENÇAS CARDIOVASCULARES; HIPERCOLESTEROLEMIA; COLESTEROL; DOENÇAS GENÉTICAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of clinical lipidology
- ISSN: 1933-2874
- Volume/Número/Paginação/Ano: v. 12, n. 4, p. 958-965, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RIDKER, Paul M. et al. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab. Journal of clinical lipidology, v. 12, n. 4, p. 958-965, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2018.03.088. Acesso em: 12 out. 2024. -
APA
Ridker, P. M., Santos Filho, R. D. dos, Rose, L. M., Kastelein, J. J. P., Wei, C., Revkin, J., et al. (2018). Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab. Journal of clinical lipidology, 12( 4), 958-965. doi:10.1016/j.jacl.2018.03.088 -
NLM
Ridker PM, Santos Filho RD dos, Rose LM, Kastelein JJP, Wei C, Revkin J, YUNIS C, Tardif J-C, Shear CL. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab [Internet]. Journal of clinical lipidology. 2018 ; 12( 4): 958-965.[citado 2024 out. 12 ] Available from: https://doi.org/10.1016/j.jacl.2018.03.088 -
Vancouver
Ridker PM, Santos Filho RD dos, Rose LM, Kastelein JJP, Wei C, Revkin J, YUNIS C, Tardif J-C, Shear CL. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab [Internet]. Journal of clinical lipidology. 2018 ; 12( 4): 958-965.[citado 2024 out. 12 ] Available from: https://doi.org/10.1016/j.jacl.2018.03.088 - Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia
- Increased Physical Activity is Associated With Lower Risk of Non Alcoholic Fatty Liver Disease Across Spectrum of Cardiometabolic Risk
- Hematocrit Level is Associated With Subclinical Vascular Inflammation in a Middle-Aged Brazilian Population
- Statin Use Protects Against Systemic Inflammation in a Geriatric Population: The Brazilian Study on Healthy Aging
- Lipid Accumulation Product (LAP) is Associated With Subclinical Vascular Inflammation in Persons Without Metabolic Syndrome
- Delayed Heart Rate Recovery is Strongly Associated With Early and Late-Stage Prehypertension During Exercise Stress Testing
- Impact of Fitness Versus Obesity on Routinely Measured Cardiometabolic Risk in Young, Healthy Adults
- A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
- Impact of a decade of action on prevention of hypertension and anthropometry of school students
- Concentração de Ácidos Graxos e Colesterol de Peixes Habitualmente Consumidos no Brasil
Informações sobre o DOI: 10.1016/j.jacl.2018.03.088 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
